Home/Filings/4/0000899243-17-001543
4//SEC Filing

INOTEK PHARMACEUTICALS CORP 4

Accession 0000899243-17-001543

$RCKTCIK 0001281895operating

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:31 PM ET

Size

5.5 KB

Accession

0000899243-17-001543

Insider Transaction Report

Form 4
Period: 2017-01-17
RITTER DALE
Vice President, Finance
Transactions
  • Award

    Restricted Stock Units

    2017-01-17+50,00050,000 total
    Exp: 2027-01-16Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of ITEK common stock.
  • [F2]The restricted stock units were issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan (the "Plan"). The restricted stock units shall vest in equal 25% tranches every 6 months over a 2 year period from the date of grant, subject to continued service through such dates.

Issuer

INOTEK PHARMACEUTICALS CORP

CIK 0001281895

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001281895

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:31 PM ET
Size
5.5 KB